Logo
x

Search

Subscribe Now

Five

Sarepta Signs a Two-Year Research and Option Agreement with Codiak for Up to Five Neuromuscular Targets

Sarepta Signs a Two-Year Research and Option Agreement with Codiak for Up to Five Neuromuscular Targets

  • June 24, 2020
GSK Signs a Five Years Collaboration with Lyell to Develop Technologies Improving Cell Therapies for Cancer

GSK Signs a Five Years Collaboration with Lyell to Develop Technologies Improving Cell Therapies for Cancer

  • October 9, 2019
Pfizer's Zirabev (biosimilar- bevacizumab) Receives the US FDA's Approval for Five Types of Cancer

Pfizer's Zirabev (biosimilar- bevacizumab) Receives the US FDA's Approval for Five Types of Cancer

  • June 28, 2019
Xoma Purchases Royalty Rights for Aronora's Five Preclinical and Clinical Hematology Candidates

Xoma Purchases Royalty Rights for Aronora's Five Preclinical and Clinical Hematology Candidates

  • April 8, 2019
Crown Laboratories Acquires Rights for GSK's Five OTC Drugs

Crown Laboratories Acquires Rights for GSK's Five OTC Drugs

  • December 4, 2018
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.